Baoting Zhang
Affiliations: | Orthopaedics and Traumatology | The Chinese University of Hong Kong, Hong Kong, Hong Kong |
Area:
General, Pharmaceutical Chemistry, PharmacyGoogle:
"Baoting Zhang"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhuo Z, Wan Y, Guan D, et al. (2020) A Loop-Based and AGO-Incorporated Virtual Screening Model Targeting AGO-Mediated miRNA-mRNA Interactions for Drug Discovery to Rescue Bone Phenotype in Genetically Modified Mice. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 7: 1903451 |
| Liang C, Li J, Lu C, et al. (2020) Author Correction: HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis. Nature Communications. 11: 3098 |
| Zhang N, Zhang ZK, Yu Y, et al. (2020) Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy. Frontiers in Cell and Developmental Biology. 8: 325 |
| He X, Liu J, Liang C, et al. (2020) Corrigendum to 'Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis' [EBioMedicine 41 (2019) 538-555]. Ebiomedicine. 52: 102669 |
| Liang C, Li J, Lu C, et al. (2019) HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis. Nature Communications. 10: 4579 |
| He X, Liu J, Liang C, et al. (2019) Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis. Ebiomedicine |
| Zheng Y, Wang X, Zhang ZK, et al. (2019) Bushen Yijing Fang Reduces Fall Risk in Late Postmenopausal Women with Osteopenia: A Randomized Double-blind and Placebo-controlled Trial. Scientific Reports. 9: 2089 |
| Liang C, Peng S, Li J, et al. (2018) Inhibition of osteoblastic Smurf1 promotes bone formation in mouse models of distinctive age-related osteoporosis. Nature Communications. 9: 3428 |
| Li F, Lu J, Liu J, et al. (2017) A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer. Nature Communications. 8: 1390 |
| Liang C, Li F, Wang L, et al. (2017) Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGFA in osteosarcoma. Biomaterials. 147: 68-85 |